Stocks and Investing Stocks and Investing
Wed, August 16, 2023

Whitney Ijem Maintained (TSHA) at Strong Buy with Decreased Target to $7 on, Aug 16th, 2023


Published on 2024-10-28 05:56:08 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Canaccord Genuity, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $13 to $7 on, Aug 16th, 2023.

Whitney has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Whitney's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Whitney


  • Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, August 15th, 2023
  • Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $6 on, Tuesday, August 15th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023

Contributing Sources